New hires and promotions in the biopharma industry, including: Asklepios, Glycomimetics, Morphic.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Ansun, Apeiron, Cytodyn, Eusa, Hutchison China Meditech, I-Mab, Inflarx, Inovio, Kiniksa, Nanocarrier, Novan, Oncoceutics, Sato, Synairgen, Vanda, VBL.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Applied, Celularity, Cytodyn, Eisai, Faron, Gracell, I-Mab, Mallinckrodt, Mesoblast, Novoteris, Pharmamar, Revive, Takeda.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Adaptive, Alnylam, Amgen, Ansun, Assembly, Astellas, Aurobindo, Bioaegis, Bioardis, Bionomics, Brii, Capricor, Carterra, Celltrion, Celularity, Cytodyn, Diffusion, Eisai, Ennaid, Evotec, Evqlv, Flexion, Flugen, GSK, Ildong, Incyte, Innate, Innovation, Junshi, Kalos, Kleo, Lee's, Macromoltek, Mateon, Medincell, Modalis, Novartis, Noxopharm, Nuvo, Ocumension, Onxeo, Ostrich, Otsuka, Persephone, Premas, Primmune, Sanbio, Seikagaku, Seneca, Shenogen Pharma, Sirona, Sorrento, Takeda, Ultragenyx, Vaxart, Vir, Viscient, Voltron.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acumen Research Laboratories, Allurion Technologies, Almac Clinical Technologies, Artms Products, Beam Therapeutics, Bio-Rad Laboratories, Biotricity, Cure Pharmaceutical, Getinge, Imaginab, Invitae, Ivwatch, James Fisher, The Janz, Medipines, Mesa Biotech, Mirion, Nano-X, Oklahoma State University, Qure.ai, OGT, Parallax, Rapid Medical, United Global Alliance, Vortran, Xerox.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cochlear, Genetron, Gnomegen, Motus GI, Nitiloop, Orthosensor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ingeneron,Theranica.

Med-tech firms raising money in public or private financings, including: Akers Biosciences, Cybermdx, Datos Health, Invitae, Monarch Biosciences, Tyto Care.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Propanc Biopharma.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Agenus, Alnylam, Ascentage, Blaze, Immunomedics, Merck.